This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Mouse Anti-Canine Wilms Tumor 1 Monoclonal Antibody
Product Overview
BioVenic mouse monoclonal antibody is specific for canine wilms tumor 1. It can be applied to IHC assay of canine wilms tumor 1.
Specifications
Target Information
Canine wilms tumor 1 (WT1) is a protein that has been investigated for its expression in various human cancers as a target molecule for cancer immunotherapy. In dogs, WT1 expression has been detected in all canine lymphoma tissues and in some normal canine tissues, including the kidney and lymph node. The cDNA of canine WT1 (cWT1) has been molecularly cloned from normal canine kidney, and the cross-reactivity of the anti-human WT1 monoclonal antibody (6F-H2) with cWT1 has been confirmed. cWT1 is considered a potential immunotherapy target against canine cancers, highlighting its significance in both normal cellular development and in the progression of canine cancers.
Shipping and Storage
This product is shipped with wet ice packs. Store at -20°C on receipt (up to 12 months). Avoid repeated freezing and thawing as this may denature the antibody.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.